When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ZYNE - Despite Negative Reaction To Safety Profile Zynerba's Zygel Results Are Actually Pretty Normal
Zynerba Pharmaceuticals Inc.
The confusing case of Zynerba (ZYNE) continues to show that the medical cannabis space is basically completely unpredictable. The stock is down about a third since announcing what it called positive results for its Zygel transdermal cannabidiol [CBD] treatment for various forms of childhood epilepsy. Traders didn't see it that way it seems, even though the results at this stage were not that much different from the results of GW Pharmaceuticals' (GWPH) Epidiolex. Both in terms of efficacy and safety, results for these two different forms of CBD treatment were qualitatively